CARB-X funds VenatoRx to support development of new class of oral antibiotics to treat multi-drug-resistant gonorrhoea

Image: VenatoRx Pharmaceuticals will develop a new class of oral antibiotics to treat multi-drug-resistant gonorrhoea. Photo: courtesy of moritz320 from Pixabay.